🔎 Trials Near Me

Home › Blood Cancers › California › San Francisco

Blood Cancers clinical trials in San Francisco, CA

8 studies for Blood Cancers are looking for participants at sites in and around San Francisco (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

RecruitingPhase 3
  • UCSF Helen Diller Family Comprehensive Cancer Center ( Site 0004), San Francisco
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT03486873

Wearable Activity Tracking to Curb Hospitalizations

RecruitingObservational study
  • University of California, San Francisco, San Francisco
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT06587100

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

RecruitingObservational study
  • Zuckerberg San Francisco General Hospital, San Francisco
All ages · All sexes · Updated Sep 17, 2026 · NCT04242095

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

RecruitingPhase 1
  • University of California San Francisco, San Francisco
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT06001788

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RecruitingObservational study
  • UCSF (Peds), San Francisco
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

RecruitingObservational study
  • University of California, San Francisco, San Francisco
Ages 18 and older · All sexes · Updated Jun 1, 2026 · NCT05663502

A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients

RecruitingPhase 3
  • UCSF Medical Center-Mission Bay, San Francisco
Ages 2 to 18 · All sexes · Updated May 5, 2026 · NCT05711667

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

RecruitingPhase 1
  • UCSF School of Medicine, San Francisco
Ages 1 to 21 · All sexes · Updated Dec 6, 2024 · NCT05476770

Blood Cancers trials in other cities

Other studies in San Francisco

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.